- taking ductoscopy to the next level -


Abegaill B.V. is a young company dedicated to develop medical devices in the field of ductoscopy. The ultimate goal is to treat pre(malignant) breast disease.

Abegaill successfully closes seed funding round

Rotterdam, December 21th, 2017 – Abegaill B.V. announces the successfully closing of a seed funding round. This funding is provided by Swanbridge Capital, a Dutch life science venture capital fund, and Leander Healthcare, a Benelux medtech innovation provider. Edwin Leander has been appointed as the company’s CEO.

Lees meer